Docetaxel

nuclear factor kappa B subunit 1 ; Homo sapiens







25 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30765600 Cytochrome c Deficiency Confers Apoptosome and Mitochondrial Dysfunction in African-American Men with Prostate Cancer. 2019 Apr 1 1
2 28485511 Combination of Nexrutine and docetaxel suppresses NFκB-mediated activation of c-FLIP. 2017 Oct 1
3 26263379 Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer. 2015 1
4 24741455 Curcumin Enhances Docetaxel-Induced Apoptosis of 8505C Anaplastic Thyroid Carcinoma Cells. 2014 Mar 1
5 24925528 Activation of nuclear factor κB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancer. 2014 Oct 15 1
6 23038213 Nuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancer. 2013 Apr 1
7 23138939 γ-tocotrienol enhances the chemosensitivity of human oral cancer cells to docetaxel through the downregulation of the expression of NF-κB-regulated anti-apoptotic gene products. 2013 Jan 4
8 21982118 Characterisation and manipulation of docetaxel resistant prostate cancer cell lines. 2011 Oct 7 5
9 19850643 Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. 2010 Apr 1
10 20056115 Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB. 2010 Apr 10 2
11 20618955 NF-kappaB activation enhances cell death by antimitotic drugs in human prostate cancer cells. 2010 Jul 9 5
12 19414318 A protein-bound polysaccharide, PSK, enhances tumor suppression induced by docetaxel in a gastric cancer xenograft model. 2009 Mar 7
13 19531569 Thiacremonone augments chemotherapeutic agent-induced growth inhibition in human colon cancer cells through inactivation of nuclear factor-{kappa}B. 2009 Jun 1
14 19834284 Obovatol enhances docetaxel-induced prostate and colon cancer cell death through inactivation of nuclear transcription factor-kappaB. 2009 Oct 1
15 18426800 The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells. 2008 Jul 25 2
16 19050703 Dexamethasone potentiates the antiangiogenic activity of docetaxel in castration-resistant prostate cancer. 2008 Dec 16 1
17 17638896 Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer. 2007 Jul 15 2
18 17913854 Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells. 2007 Oct 5
19 16613577 The role of genistein and synthetic derivatives of isoflavone in cancer prevention and therapy. 2006 Apr 1
20 16622259 Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients. 2006 Apr 20 1
21 15956258 The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer. 2005 Jun 1
22 16061678 Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. 2005 Aug 1 1
23 15097869 Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line. 2004 May 2
24 12687011 PSK-mediated NF-kappaB inhibition augments docetaxel-induced apoptosis in human pancreatic cancer cells NOR-P1. 2003 Apr 10 6
25 14614027 Cyclosporin-A enhances docetaxel-induced apoptosis through inhibition of nuclear factor-kappaB activation in human gastric carcinoma cells. 2003 Nov 1 1